Onconova Therapeutics- Warrants (01/08/2021) Profit Margin

As of the most recent data (March 2026), ONTXW shows a profit margin of 321546.12%. That compares with -8797.22% in the prior-year period — up 3755.1% year over year. That is above the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ONTXW's profit margin is now 321546.12% (was -8797.22%) — a 3755.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Onconova Therapeutics- Warrants (01/08/2021) is outperforming or lagging.

The Healthcare sector average profit margin is about 14.34%. Onconova Therapeutics- Warrants (01/08/2021) is at 321546.12%, which is higher that average. That is roughly 2241454.8% above the sector mean. Use the comparison chart on this page to see how ONTXW stacks up against individual peers as well.

That compares with -8797.22% in the prior-year period — up 3755.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Onconova Therapeutics- Warrants (01/08/2021) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Onconova Therapeutics- Warrants (01/08/2021)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 321546.12%) with ownership activity and broader fundamentals.